THERE'S MORE TO SEE Trademark

Trademark Overview

On Wednesday, March 20, 2013, a trademark application was filed for THERE'S MORE TO SEE with the United States Patent and Trademark Office. The USPTO has given the THERE'S MORE TO SEE trademark a serial number of 79129736. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, March 20, 2023. This trademark is owned by Sanochemia Diagnostics Deutschland GmbH. The THERE'S MORE TO SEE trademark is filed in the Pharmaceutical Products category with the following description:

Test reagents for medical diagnosis; contrast media for use with X-ray, ultrasound and MRI medical and veterinary imaging equipment; pharmaceutical products, namely, pharmaceutical preparations for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus, vasculitis, cancer, IBD, namely, ulcerative colitis and Crohn's disease, psoriasis, cutaneous lupus erythematosus, dermatitis, pemphigus, multiple sclerosis, demyelinating autoimmune diseases, Guillain-Barresyndrome neuromyelitis optica, myasthenia gravis, opthalmia, asthma, allergic rhinitis,hypersensitivity, anemia, diabetes mellitus, cardiovascular diseases, namely, anginapectoris, hypertension, myocardia infraction, CNS-disorders, namely, depression,schizophrenia, muscular spasm and pain epilepsy
there's more to see

General Information

Serial Number79129736
Word MarkTHERE'S MORE TO SEE
Filing DateWednesday, March 20, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, March 20, 2023
Registration Number4457138
Registration DateTuesday, December 31, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2013

Trademark Statements

Goods and ServicesTest reagents for medical diagnosis; contrast media for use with X-ray, ultrasound and MRI medical and veterinary imaging equipment; pharmaceutical products, namely, pharmaceutical preparations for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus, vasculitis, cancer, IBD, namely, ulcerative colitis and Crohn's disease, psoriasis, cutaneous lupus erythematosus, dermatitis, pemphigus, multiple sclerosis, demyelinating autoimmune diseases, Guillain-Barresyndrome neuromyelitis optica, myasthenia gravis, opthalmia, asthma, allergic rhinitis,hypersensitivity, anemia, diabetes mellitus, cardiovascular diseases, namely, anginapectoris, hypertension, myocardia infraction, CNS-disorders, namely, depression,schizophrenia, muscular spasm and pain epilepsy
Pseudo MarkTHERE IS MORE TO SEE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanochemia Diagnostics Deutschland GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameSanochemia Diagnostics Deutschland GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameSanochemia Diagnostics Deutschland GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Friday, November 17, 2023UNDELIVERABLE MAIL - NO ACTION TAKEN
Sunday, October 15, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, October 15, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, March 13, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, February 17, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, February 17, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Thursday, August 29, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 13, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 29, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 29, 2014FINAL DISPOSITION PROCESSED
Thursday, April 17, 2014NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 31, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, March 27, 2014NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 31, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, October 15, 2013NOTIFICATION PROCESSED BY IB
Tuesday, October 15, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 25, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 25, 2013NOTICE OF PUBLICATION
Tuesday, September 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 10, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 5, 2013EXAMINERS AMENDMENT MAILED
Thursday, September 5, 2013DATA MODIFICATION COMPLETED
Thursday, September 5, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, September 5, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 4, 2013AMENDMENT FROM APPLICANT ENTERED
Wednesday, September 4, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 29, 2013PAPER RECEIVED
Monday, August 26, 2013AMENDMENT FROM APPLICANT ENTERED
Monday, August 26, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 21, 2013ASSIGNED TO LIE
Friday, August 16, 2013PAPER RECEIVED
Saturday, July 27, 2013REFUSAL PROCESSED BY IB
Friday, July 5, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 5, 2013REFUSAL PROCESSED BY MPU
Thursday, July 4, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 3, 2013NON-FINAL ACTION WRITTEN
Friday, June 28, 2013ASSIGNED TO EXAMINER
Tuesday, June 4, 2013APPLICATION FILING RECEIPT MAILED
Wednesday, May 29, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 24, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 23, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

more namely arthritis rheumatoid medical lupus pharmaceutical diseases rhinitis guillain hypersensitivity